Gene: APOBEC3F
Official Full Name: apolipoprotein B mRNA editing enzyme catalytic subunit 3Fprovided by HGNC
Gene Summary: This gene is a member of the cytidine deaminase gene family. It is one of seven related genes or pseudogenes found in a cluster, thought to result from gene duplication, on chromosome 22. Members of the cluster encode proteins that are structurally and functionally related to the C to U RNA-editing cytidine deaminase APOBEC1. It is thought that the proteins may be RNA editing enzymes and have roles in growth or cell cycle control. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO38219 | APOBEC3F Knockout cell line (HCT 116) | Human | APOBEC3F | 1:2~1:4 | Negative | Online Inquiry |
KO38220 | APOBEC3F Knockout cell line (HEK293) | Human | APOBEC3F | 1:3~1:6 | Negative | Online Inquiry |
KO38221 | APOBEC3F Knockout cell line (A549) | Human | APOBEC3F | 1:3~1:4 | Negative | Online Inquiry |
APOBEC3F Gene Knockout Cell Lines are genetically engineered cell lines specifically designed to lack the expression of the APOBEC3F gene, which encodes a cytidine deaminase that plays a pivotal role in innate immunity against viral infections and retrotransposon activity. By creating these knockout models, researchers can delve into the functional significance of APOBEC3F in various biological contexts, including viral mutagenesis, cancer progression, and immune evasion mechanisms.
The key functions of APOBEC3F revolve around its ability to deaminate cytosine residues in viral RNA and DNA, leading to hypermutation and ultimately the inhibition of viral replication. The knockout of this gene facilitates a controlled environment to study both the absence of APOBEC3F and the resulting phenotypic changes, allowing for in-depth analyses of viral response and host-pathogen interactions.
In research and clinical settings, these cell lines are invaluable for elucidating the role of APOBEC3F in disease mechanisms, particularly in the context of HIV infections and oncogenic processes. Their application extends to the development of therapeutic interventions targeting retroviral infections and cancer treatment strategies that leverage the pathways influenced by APOBEC enzymes.
Compared to alternatives, the uniqueness of the APOBEC3F Gene Knockout Cell Lines lies in their specificity and reliability as models. These lines allow for reproducible studies, enabling researchers to draw consistent conclusions about the biological activities associated with the APOBEC3F gene.
For researchers and clinicians, the ability to manipulate and study these cell lines provides a significant advantage in understanding complex biological pathways, ultimately leading to innovations in therapeutic approaches.
At our company, we pride ourselves on our extensive expertise in the development of advanced biological products and cell lines that empower scientific discovery and clinical innovation, ensuring that researchers have access to the highest quality tools for their work.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.